Chronic hepatitis C – what do the new drugs offer and who should get them first?

gan Ryder, Stephen D
Cyhoeddwyd yn Clin Med (Lond) (2015)

Screening for hepatocellular carcinoma: patient selection and perspectives

gan Fateen, Waleed, Ryder, Stephen D
Cyhoeddwyd yn J Hepatocell Carcinoma (2017)

Epistaxis: an overlooked cause of massive haematemesis in cirrhosis

gan Johal, Shawinder S, Austin, Andrew S, Ryder, Stephen D
Cyhoeddwyd 2003

Biochemical “liver function tests”

gan Smellie, W Stuart A, Ryder, Stephen D
Cyhoeddwyd 2006

The Utility of Scoring Systems in Predicting Early and Late Mortality in Alcoholic Hepatitis: Whose Score Is It Anyway?

gan Palaniyappan, Naaventhan, Subramanian, Venkataraman, Ramappa, Vidyasagar, Ryder, Stephen D., Kaye, Philip, Aithal, Guruprasad P.
Cyhoeddwyd 2012

Getting involved in clinical trials research in the UK: how can Clinical Research Networks help?

gan Hull, Mark A, Yiannakou, Yan, Gower, Jonathan, Ryder, Stephen D, Bloom, Stuart L, Rees, Colin R
Cyhoeddwyd yn Frontline Gastroenterol (2012)

Healthcare costs of transarterial chemoembolization in the treatment of hepatocellular carcinoma

gan Fateen, Waleed, Khan, Farooq, O’NeiSSll, Richard J, James, Martin W, Ryder, Stephen D, Aithal, Guruprasad P
Cyhoeddwyd yn J Hepatocell Carcinoma (2017)

The Utility of Liver Function Tests for Mortality Prediction within One Year in Primary Care Using the Algorithm for Liver Function Investigations (ALFI)

gan McLernon, David J., Dillon, John F., Sullivan, Frank M., Roderick, Paul, Rosenberg, William M., Ryder, Stephen D., Donnan, Peter T.
Cyhoeddwyd 2012

Direct targeting of risk factors significantly increases the detection of liver cirrhosis in primary care: a cross-sectional diagnostic study utilising transient elastography

gan Harman, David J, Ryder, Stephen D, James, Martin W, Jelpke, Matthew, Ottey, Dominic S, Wilkes, Emilie A, Card, Timothy R, Aithal, Guruprasad P, Guha, Indra Neil
Cyhoeddwyd yn BMJ Open (2015)

Disease burden and economic impact of diagnosed non-alcoholic steatohepatitis (NASH) in the United Kingdom (UK) in 2018

gan Morgan, Alice, Hartmanis, Sally, Tsochatzis, Emmanuel, Newsome, Philip N., Ryder, Stephen D., Elliott, Rachel, Floros, Lefteris, Hall, Richard, Higgins, Victoria, Stanley, George, Cure, Sandrine, Vasudevan, Sharad, Pezzullo, Lynne
Cyhoeddwyd yn Eur J Health Econ (2021)

Treatment with tenofovir disoproxil fumarate or entecavir in chronic hepatitis B virus‐infected patients with renal impairment: results from a 7‐year, multicentre retrospective coh...

gan Lampertico, Pietro, Berg, Thomas, Buti, Maria, Pathil, Anita, Petersen, Joerg, Ryder, Stephen D., Zoulim, Fabien, Botros, Irina, Flaherty, John F., Jump, Belinda, Op den Brouw, Marjoleine L., van Troostenburg, Anna, Ramroth, Heribert
Cyhoeddwyd yn Aliment Pharmacol Ther (2020)

In Patients With Severe Alcoholic Hepatitis, Prednisolone Increases Susceptibility to Infection and Infection-Related Mortality, and Is Associated With High Circulating Levels of B...

gan Vergis, Nikhil, Atkinson, Stephen R., Knapp, Suzanne, Maurice, James, Allison, Michael, Austin, Andrew, Forrest, Ewan H., Masson, Steven, McCune, Anne, Patch, David, Richardson, Paul, Gleeson, Dermot, Ryder, Stephen D., Wright, Mark, Thursz, Mark R.
Cyhoeddwyd yn Gastroenterology (2017)

The impact of rifaximin-α on the hospital resource use associated with the management of patients with hepatic encephalopathy: a retrospective observational study (IMPRESS)

gan Hudson, Mark, Radwan, Amr, Di Maggio, Paola, Cipelli, Riccardo, Ryder, Stephen D, Dillon, John F, Cash, William Jonathan, Przemioslo, Robert T, Wright, Mark, Shawcross, Debbie L, Jalan, Rajiv, Saksena, Sushma, Allison, Michael, Richardson, Paul, Farrington, Elizabeth, Aspinall, Richard J
Cyhoeddwyd yn Frontline Gastroenterol (2017)

NI‐0801, an anti‐chemokine (C‐X‐C motif) ligand 10 antibody, in patients with primary biliary cholangitis and an incomplete response to ursodeoxycholic acid

gan de Graaf, Kathy L., Lapeyre, Geneviève, Guilhot, Florence, Ferlin, Walter, Curbishley, Stuart M., Carbone, Marco, Richardson, Paul, Moreea, Sulleman, McCune, C. Anne, Ryder, Stephen D., Chapman, Roger W., Floreani, Annarosa, Jones, David E., de Min, Cristina, Adams, David H., Invernizzi, Pietro
Cyhoeddwyd yn Hepatol Commun (2018)

Long-term outcomes of liver transplant recipients followed up in non-transplant centres: Care closer to home

gan Tsien, Cynthia, Tan, Huey, Sharma, Sowmya, Palaniyappan, Naaventhan, Wijayasiri, Pramudi, Leung, Kristel, Hayre, Jatinder, Mowlem, Elizabeth, Kang, Rachel, Eddowes, Peter J, Wilkes, Emilie, Venkatachalapathy, Suresh V, Guha, Indra N, Antonova, Lilia, Cheung, Angela C, Griffiths, William JH, Butler, Andrew J, Ryder, Stephen D, James, Martin W, Aithal, Guruprasad P, Aravinthan, Aloysious D
Cyhoeddwyd yn Clin Med (Lond) (2021)

Glecaprevir/Pibrentasvir in patients with chronic HCV genotype 3 infection: An integrated phase 2/3 analysis

gan Flamm, Steven, Mutimer, David, Asatryan, Armen, Wang, Stanley, Rockstroh, Jürgen, Horsmans, Yves, Kwo, Paul Y., Weiland, Ola, Villa, Erica, Heo, Jeong, Gane, Edward, Ryder, Stephen D., Welzel, Tania M., Ruane, Peter J., Agarwal, Kosh, Ng, Teresa I., Xue, Zhenyi, Lovell, Sandra S., Krishnan, Preethi, Kopecky‐Bromberg, Sarah, Trinh, Roger, Mensa, Federico J., Wyles, David L.
Cyhoeddwyd yn J Viral Hepat (2018)

Disease burden and economic impact of diagnosed non‐alcoholic steatohepatitis in five European countries in 2018: A cost‐of‐illness analysis

gan Schattenberg, Jörn M., Lazarus, Jeffrey V., Newsome, Philip N., Serfaty, Lawrence, Aghemo, Alessio, Augustin, Salvador, Tsochatzis, Emmanuel, de Ledinghen, Victor, Bugianesi, Elisabetta, Romero‐Gomez, Manuel, Bantel, Heike, Ryder, Stephen D., Boursier, Jerome, Leroy, Vincent, Crespo, Javier, Castera, Laurent, Floros, Lefteris, Atella, Vincenzo, Mestre‐Ferrandiz, Jorge, Elliott, Rachel, Kautz, Achim, Morgan, Alice, Hartmanis, Sally, Vasudevan, Sharad, Pezzullo, Lynne, Trylesinski, Aldo, Cure, Sandrine, Higgins, Victoria, Ratziu, Vlad
Cyhoeddwyd yn Liver Int (2021)